Branded vs. Generic
- What’s the Difference?
Branded drugs are more expensive because they’re newer, generally groundbreaking, and often for conditions that are difficult to treat. However, after a certain period of time, these same innovative medicines become generic medicines.
- How is Pfizer Different?
The difference between our approach and that of many other companies is that when a medicine becomes a generic, we still assume responsibility. Rather than focus on just what’s in development, we continue to closely monitor the quality, safety, and reliability of our generic medicines.
Related Articles
Programs & Initiatives
Bridging the Gap: Community-Based Organizations Seek Trust, Tools and Funding to Advance Public Health
Community-based organizations (CBOs) are the cornerstone of community health—yet across the country they face substantial uncertainty, according to a new national survey supported by the Pfizer Multicultural Health Equity Collective (The Collective).
Science & Innovation
Pursuing the Next Breakthrough in Cancer Cachexia
Cachexia, a complex wasting syndrome, impacts an estimated 9 million people worldwide. Currently, there are no FDA-approved treatments targeting its underlying cause.
Science & Innovation
Brighter Together: How the Pharmaceutical Industry is Shining a Light on a Rare Cause of Heart Failure
Among the lesser known causes of heart failure is transthyretin amyloid cardiomyopathy (ATTR-CM). Early suspicion and diagnosis are crucial. That’s why Pfizer is working with other industry partners as part of the ASPIRE group, led by Amyloidosis Research Consortium (ARC), to accelerate earlier detection and diagnosis.
How Drugs Are Made
The medicines available today have taken an average of 12 years to develop. With dedication, creativity, and science, we can significantly cut that time.
